Application of Radiometallic Compounds for Medical Diagnosis and Therapy-Reference-Cited by-同舟云学术

Application of Radiometallic Compounds for Medical Diagnosis and Therapy

Published:2008-03-01 Issue:3 Volume:128 Page:323-332
ISSN:0031-6903
Container-title:YAKUGAKU ZASSHI
language:en
Short-container-title:YAKUGAKU ZASSHI

Author:

SAJI Hideo¹

Affiliation:

1. Graduate School of Pharmaceutical Sciences, Kyoto University

Publisher

Pharmaceutical Society of Japan

Subject

Pharmaceutical Science,Pharmacology

Link

https://www.jstage.jst.go.jp/article/yakushi/128/3/128_3_323/_pdf

Reference28 articles.

1. 1) Saji H., Ohomo Y., Magata Y., “Radiochemistry and Radiopharmaceuticals,” 2nd, eds. by Saji H., Maeda M., Kojima S., Nankoudou, Tokyo, 2006, pp. 127-189.

2. 2) Abrams M. J., Murrer B. A., Science, 261, 725-730 (1993).

3. 3) Banerjee S. R., Maresca K. P., Francescon L., Valliant J., Babich J. W., Zubieta J., Nucl. Med. Biol., 32, 1-20 (2005).

4. 4) Saji H, Crit. Rev. Ther. Drug Carrier Syst., 16, 209-244 (1999).

5. 5) Verbruggen A. M., “Current Directions in Radiopharmaceutical Research and Development,” ed. by Mather S. J., Kluwer Academic Publishers, Dordrecht, 1996, pp. 31-46.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Technetium-99m metastable radiochemistry for pharmaceutical applications: old chemistry for new products;Journal of Coordination Chemistry;2019-06-03

2. Preparation and biological evaluation of a carrier free 90yttrium labelled porphyrin as a possible agent for targeted therapy of tumor;Journal of Porphyrins and Phthalocyanines;2017-01

3. Impact of albumin on drug delivery — New applications on the horizon;Journal of Controlled Release;2012-01

4. Yttrium-90 (90Y) in the principal radionuclide therapies: An efficacy correlation between peptide receptor radionuclide therapy, radioimmunotherapy and transarterial radioembolization therapy. Ten years of experience (1999–2009);Critical Reviews in Oncology/Hematology;2011-12